Literature DB >> 9794130

GBV-C RNA presence in several high-risk groups of Spain.

E Quirós1, G Piédrola, M C Maroto.   

Abstract

GB virus C subtype (GBV-C) seems to share the same routes of transmission as other parenteral transmitted viruses. We have evaluated the prevalence of GBV-C in 247 patients with potential risk for GBV-C infection and in 91 healthy blood donors. The presence of GBV-C RNA was examined by polymerase chain reaction in serum samples. The 23.6% of parenteral drug users were GBV-C positive, 36.3% of them were also HIV infected. Moreover, 22.5 and 19% of sera from patients with HBV and HCV chronic hepatitis, respectively, but without apparent risk factors seemed GBV-C infected. Finally, the 6% of patients on hemodialysis were also positive. Therefore, these results suggest that GBV-C is transmitted by parenteral routes but other non-parenteral routes shared with HBV or HCV must be considered.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9794130     DOI: 10.1023/a:1007448501661

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  21 in total

1.  Phylogenetic analysis of GB virus C: comparison of isolates from Africa, North America, and Taiwan.

Authors:  J H Kao; P J Chen; S C Hsiang; W Chen; D S Chen
Journal:  J Infect Dis       Date:  1996-08       Impact factor: 5.226

Review 2.  Methods of transmission of hepatitis C.

Authors:  C J Tibbs
Journal:  J Viral Hepat       Date:  1995       Impact factor: 3.728

3.  Vertical transmission of hepatitis G.

Authors:  H H Feucht; B Zollner; S Polywka; R Laufs
Journal:  Lancet       Date:  1996-03-02       Impact factor: 79.321

4.  Detection of hepatitis G virus (GB virus C) RNA in human saliva.

Authors:  M Chen; A Sönnerborg; B Johansson; M Sällberg
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

5.  DNA enzyme immunoassay: general method for detecting products of polymerase chain reaction.

Authors:  G Mantero; A Zonaro; A Albertini; P Bertolo; D Primi
Journal:  Clin Chem       Date:  1991-03       Impact factor: 8.327

6.  Identification of two flavivirus-like genomes in the GB hepatitis agent.

Authors:  J N Simons; T J Pilot-Matias; T P Leary; G J Dawson; S M Desai; G G Schlauder; A S Muerhoff; J C Erker; S L Buijk; M L Chalmers
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

7.  Isolation of novel virus-like sequences associated with human hepatitis.

Authors:  J N Simons; T P Leary; G J Dawson; T J Pilot-Matias; A S Muerhoff; G G Schlauder; S M Desai; I K Mushahwar
Journal:  Nat Med       Date:  1995-06       Impact factor: 53.440

8.  Seroepidemiology of hepatitis B virus in a population of injecting drug users. Association with drug injection patterns.

Authors:  O S Levine; D Vlahov; J Koehler; S Cohn; A M Spronk; K E Nelson
Journal:  Am J Epidemiol       Date:  1995-08-01       Impact factor: 4.897

9.  Molecular and serologic analysis in the transmission of the GB hepatitis agents.

Authors:  G G Schaluder; G J Dawson; J N Simons; T J Pilot-Matias; R A Gutierrez; C A Heynen; M F Knigge; G S Kurpiewski; S L Buijk; T P Leary
Journal:  J Med Virol       Date:  1995-05       Impact factor: 2.327

10.  Infection with hepatitis GB virus C in patients on maintenance hemodialysis.

Authors:  K Masuko; T Mitsui; K Iwano; C Yamazaki; K Okuda; T Meguro; N Murayama; T Inoue; F Tsuda; H Okamoto; Y Miyakawa; M Mayumi
Journal:  N Engl J Med       Date:  1996-06-06       Impact factor: 91.245

View more
  3 in total

1.  Investigation of saliva, faeces, urine or semen samples for the presence of GBV-C RNA.

Authors:  Q R Eugenia; Q R Ana; M Carmen
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

2.  Genotyping and infection rate of GBV-C among Iranian HCV- infected patients.

Authors:  Reza Ghanbari; Mehrdad Ravanshad; Seyed Younes Hosseini; Ramin Yaghobi; Kiana Shahzamani
Journal:  Hepat Mon       Date:  2010-06-01       Impact factor: 0.660

3.  High HPgV replication is associated with improved surrogate markers of HIV progression.

Authors:  Gibran Horemheb-Rubio; Pilar Ramos-Cervantes; Hugo Arroyo-Figueroa; Santiago Ávila-Ríos; Claudia García-Morales; Gustavo Reyes-Terán; Galileo Escobedo; Gloria Estrada; Trinidad García-Iglesias; Nayeli Muñoz-Saucedo; David Kershenobich; Patricia Ostrosky-Wegman; Guillermo M Ruiz-Palacios
Journal:  PLoS One       Date:  2017-09-14       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.